ng28ÄϹ¬

ÌõÄ¿µÄ

ng28ÄϹ¬µÚÊ®´ÎÈÙâß¡°È«Çò100×î¾ß¿ÉÁ¬ÐøÉú³¤ÄÜÁ¦ÆóÒµ¡±³Æºô ÇÒΪÅÅÃû×î¸ßµÄÈ«ÇòÖÆÒ©ÆóÒµ

ng28ÄϹ¬Ðû²¼ £¬ÆäÒÑÈëÑ¡¼ÓÄôóýÌåÓëͶ×Ê×Éѯ¹«Ë¾ Corporate Knights, Inc. Ðû²¼µÄ¡¶2026 ÄêÈ«Çò 100 ×î¾ß¿ÉÁ¬ÐøÉú³¤ÄÜÁ¦ÆóÒµ°ñµ¥¡·£¨Global 100£©¡£ÕâÊÇng28ÄϹ¬µÚÊ®´ÎÈٵǸðñµ¥¡£ÔÚ´Ë´ÎÅÅÃûÖÐ £¬ng28ÄϹ¬Î»ÁÐµÚ 36 Ãû £¬²»¿ÉÊÇÈ«ÇòÖÆÒ©ÆóÒµÖÐÅÅÃû×î¸ßµÄÆóÒµ £¬Ò²ÊÇ¡¶È«Çò 100¡·°ñµ¥ÖÐÅÅÃû×î¸ßµÄÈÕ±¾ÆóÒµ¡£

Î÷°²½»´óҩѧԺ¾Ù°ìng28ÄϹ¬Öйú½±½Ì½ð°ä½±ÒÇʽ

½üÈÕ £¬Î÷°²½»Í¨´óѧҩѧԺ¾Ù°ìng28ÄϹ¬Öйú½±½Ì½ð°ä½±ÒÇʽ¡£ng28ÄϹ¬Öйú±±Öйú×¼È벿¸ß¼¶´óÇø¾­ÀíÀ×Ö¾Ó £¬Î÷°²½»Í¨´óѧҩѧԺԺ³¤ÍõËÃÜË¡¢µ³Î¯Êé¼ÇÕÅÑåÃñ¡¢¸±Ôº³¤·½ÓîµÈ³öϯ°ä½±ÒÇʽ¡£

ÉòÑôÒ©¿Æ´óѧ¾Ù°ì2024-2025ѧÄê¶È ng28ÄϹ¬Öйú½±Öúѧ½ð°ä½±ÒÇʽ

½üÈÕ £¬ÉòÑôÒ©¿Æ´óѧ¹¤ÉÌÖÎÀíÑ§ÔºÂ¡ÖØ¾ÙÐÐ2024 – 2025ѧÄê¶Èng28ÄϹ¬Öйú½±Öúѧ½ð°ä½±ÒÇʽ¡£ng28ÄϹ¬Öйú±±Öйú×¼È벿ÕÔ½¨¾ý²¿³¤Áìµ¼½ðΰ¾­Àí¡¢ÖÜÏþ¶¬¾­Àí £¬ÓëÉòÑôÒ©¿Æ´óѧ¹¤ÉÌÖÎÀíѧԺµ³Î¯ÍõË«ÑÞÊé¼Ç¡¢ÍõÊçÁḱԺ³¤µÈÁìµ¼³öϯÁËÒÇʽ £¬Ñ§Ôºµ³Î¯ºî´º·å¸±Êé¼ÇÖ÷³ÖÒÇʽ¡£

ÆßÔØÁ¬ÈΣ¡ng28ÄϹ¬ÖйúÔÙ»ñ¡°½Ü³ö¹ÍÖ÷¡±³Æºô

ng28ÄϹ¬Á¬ÐøµÚÆßÄêÈÙ»ñ¡°½Ü³ö¹ÍÖ÷¡±³Æºô £¬ÔÙ¶ÈÕÃÏÔÆä×÷Ϊһ¼ÒÆóÒµ £¬ÔÚ´òÔì×î¼ÑÊÂÇ鳡ºÏ·½ÃæµÄ׿Խ³É¼¨¡£

ng28ÄϹ¬ÖйúÒ©ÒµÓëÐûÎäÒ½Ôº¸æ¿¢Õ½ÂÔÏàÖú ¹²ÖþÒ½Ò©Á¢ÒìÉú³¤ÐÂÉú̬

ng28ÄϹ¬£¨ÒÔϼò³Æ¡°ng28ÄϹ¬ÖйúÒ©Òµ¡±£©ÓëÊ×¶¼Ò½¿Æ´óѧÐûÎäÒ½Ôº£¨ÒÔϼò³Æ¡°ÐûÎäÒ½Ôº¡±£©ÔÚÓѺÃЭÉ̵Ļù´¡ÉÏ £¬ÕýʽǩÊð¡¶Õ½ÂÔÏàÖú¿ò¼ÜЭÒé¡·¡£´Ë´ÎÏàÖú±ê¼Ç×ÅË«·½ÔÚÒ½Ò©ÁìÓò¿ªÆôÉî¶ÈЭͬ¡¢»¥Àû¹²Ó®µÄÐÂÆªÕ £¬½«ÎªÒ½Ò©ÎÀÉúÊÂÒµµÄ¸ßÖÊÁ¿Éú³¤×¢ÈëÇ¿¾¢¶¯Á¦¡£

ng28ÄϹ¬ÖйúÁ¢ÒìÍ´·çÒ©Îï¶àÌæÅµÀׯ¬ÀÖ³ÉÄÉÈë¹ú¼ÒÒ½±£Ä¿Â¼

½üÈÕ £¬¹ú¼ÒÒ½Áưü¹Ü¾ÖÕýʽÐû²¼ÁË¡¶¹ú¼Ò»ù±¾Ò½Áưü¹Ü¡¢¹¤É˰ü¹ÜºÍÉúÓý°ü¹ÜҩƷĿ¼£¨2025Ä꣩¡·¡£ng28ÄϹ¬ÖйúÆìϵÄÖØ°õÁ¢ÒìÍ´·çÖÎÁÆÒ©Î¡ª¶àÌæÅµÀׯ¬ÀÖ³ÉÈëѡаæÄ¿Â¼ £¬²¢½«ÓÚ2026Äê1ÔÂ1ÈÕÆðÕýʽÉúЧִÐС£´Ë¾Ù²»¿ÉÊǶԸÃÒ©ÎïÁÙ´²¼ÛÖµµÄȨÍþÈÏ¿É £¬¸üÒâζ×ÅÎÒ¹úÊýÒÔǧÍò¼ÆµÄÍ´·ç°é¸ßÄòËáѪ֢»¼Õß £¬½«ÄÜÒÔ¸ü¿Éµ£¸ºµÄ¼Û¸ñ £¬»ñµÃÕâÒ»Ç°ÑØ¡¢¸ßЧµÄÖÎÁÆÐÂÑ¡Ôñ £¬ÓÐÍûÏÔÖøÌáÉýºã¾ÃÖÎÁÆÒÀ´ÓÐÔÓë¼²²¡ÖÎÀíÖÊÁ¿¡£

ng28ÄϹ¬ÖйúÈý¿îÁ¢ÒìÒ©ÄÉÈë¹ú¼ÒÒ½±£¡¢É̱£Ä¿Â¼ 2026 Äê 1 Ô 1 ÈÕÆð»Ý¼°È«¹ú»¼Õß

2026 Äê 1 Ô 1 ÈÕÆð £¬2025 °æ¡¶¹ú¼Ò»ù±¾Ò½Áưü¹Ü¡¢ÉúÓý°ü¹ÜºÍ¹¤É˰ü¹ÜҩƷĿ¼¡·ÓëÊ×Åú¡¶ÉÌÒµ½¡¿µ°ü¹ÜÁ¢ÒìҩƷĿ¼¡·½«ÔÚÈ«¹ú¹æÄ£ÄÚÕýʽÂäµØÊµÊ©¡£

ng28ÄϹ¬Á¬ÐøÁ½ÄêÈÙâßCDPÆøºò±ä¸ï¼°Ë®Äþ¾²Àà±ð×î¸ß¡°A¡±¼¶

ng28ÄϹ¬Ðû²¼ £¬Òѱ»È«ÇòÇé¿ö·ÇÓªÀû×éÖ¯CDPÆÀѡΪ2025ÄêÆøºò±ä¸ïºÍË®Äþ¾²ÁìÓòµÄ×î¸ßÆÀ¼¶¡°A¡±°ñµ¥ÆóÒµ¡£ÕâÊÇng28ÄϹ¬Á¬ÐøµÚ¶þÄêͬʱÔÚÕâÁ½¸öÀà±ðÈëÑ¡CDP¡°A¡±°ñµ¥¡£

ng28ÄϹ¬½«ÔÚCTAD 2025ÉÏÐû²¼¿¹Tau¿¹ÌåEtalanetug£¨E2814£©ÐÂÊý¾Ý

ng28ÄϹ¬Ðû²¼ £¬ÔÚµÚÊ®°Ë½ì°¢¶û´Äº£Ä¬²¡ÁÙ´²ÊÔÑé´ó»á£¨Clinical Trials on Alzheimer¡¯s Disease Conference £¬CTAD£©ÉÏÐû²¼ÁË¿¹tau¿¹ÌåEtalanetug£¨Ñз¢´úºÅ£ºE2814£©µÄÐÂÊý¾Ý¡£EtalanetugÖ¼ÔÚÓëtauÂѰ׵Ä΢¹Ü½áºÏÇøÓò£¨microtubule-binding region £¬MTBR£©Ïà½áºÏ £¬×èÖ¹tau²¡ÀíµÄ³ÉºË£¨ÖÖ×ÓÐγɣ©ÓëÀ©É¢¡£

×îÐÂÊý¾ÝÖ¤ÊµÂØ¿¨Ä¹¶ÔÄÔ¼¹ÒºÖÐÉñ¾­¶¾ÐÔA¦ÂÔ­ÏËάµÄÒ©Àíѧ×÷ÓÃ

ng28ÄϹ¬Óë²³½¡Ðû²¼ £¬ÔÚµÚÊ®°Ë½ì°¢¶û´Äº£Ä¬²¡ÁÙ´²ÊÔÑ飨CTAD£©¼¯»áÉÏÐû²¼×îÐÂÊý¾Ý £¬Ö¤ÊµÁË¿¹A¦ÂÔ­ÏËά*¿¹Ì塪¡ªÂØ¿¨Ä¹¶ÔÄÔ¼¹Òº£¨CSF£©ÖÐA¦ÂÔ­ÏËά£¨PF£©µÄÒ©Àíѧ×÷Ó᣸ÃÑо¿½á¹ûÀ´×ÔÒ»Ïî´ó¹æÄ£ÁÙ´²ÊÔÑé £¬Ê״αêÃ÷¿ÉÔÚÄÔ¼¹ÒºÖмì²âµ½ÂØ¿¨Ä¹ÓëÔ­ÏËάµÄ½áºÏÇé¿ö £¬ÕâÓÐÖúÓÚ½øÒ»²½Á˽âÂØ¿¨Ä¹ÈçºÎ¼õ»º°¢¶û´Äº£Ä¬²¡£¨AD£©µÄ½øÕ¹¡£

ÍøÕ¾µØÍ¼